Secondary Prevention for Atherosclerotic Cardiovascular Disease Resource Center | SCAI

Secondary Prevention for Atherosclerotic Cardiovascular Disease Resource Center

The SCAI Secondary Prevention Resource Center aims to reaffirm the role of the interventional cardiologist in recognizing system-level gaps in the care of PCI patients, as well as to provide resources aimed at reducing significant barriers to providing optimal care.

The SCAI Secondary Prevention for Atherosclerotic Cardiovascular Disease Resource Center is supported by Amgen.

Content updated August 28, 2024.

Optimal Management of Lipids for Secondary Prevention

This PowerPoint slide deck discusses systemic gaps in care in PCI patients and provides information to facilitate communication across the multidisciplinary care team to ensure that our patients receive optimal guideline directed lipid-lowering therapy for secondary prevention. It also introduces resources to empower patients with the knowledge necessary to make decisions about setting and achieving their target lipid levels, as well as tools for healthcare providers to potentially aid access to necessary lipid-lowering medications.

Achieving Better Long-Term PCI Outcomes: Secondary Prevention for Your Patients

This PowerPoint slide deck gives healthcare providers an overview of the modifiable risk factors for ASCVD and introduces tools to facilitate discussions with patients on barriers to making lifestyle changes that can reduce their risk.

Lipid Lowering Agents Shared Decision-Making Tool

An overview for patients of various pharmacological options for ASCVD treatment, including statins, ezetimibe, PCSK9 inhibitors, inclisiran and bempedoic acid.

ASCVD Patient Journey

A graphical representation that outlines and demystifies for patients the pathway from ASCVD diagnosis, initial treatment, heart attack prevention and follow-up.

Checklist for Patients

A tool to facilitate discussion between healthcare providers and patients about the care they’ve received, potential lifestyle changes that can reduce the risk of a future cardiovascular event, and barriers to enacting those changes.

PCSK9 Inhibitors Prior Authorization Form

A fillable PDF that can be used by practitioners to provide prior authorization for treatment of statin-resistant ASCVD with PCSK9i.

Denial Appeal Form

A fillable PDF to use in response to a claim denial for PCSK9i.

Online Learning

Complete this online learning activity which explores the gaps in ASCVD care and how interventional cardiologists can address those gaps by applying guideline-directed care. 

Quality Improvement

SCAI offers unique resources to help members engage in continuous improvement that refines cath lab processes and systems to deliver optimal patient care. These practical tools and techniques can have a significant impact on your practice.